.

follow-on-google-news

Multibagger Agrochemical stock engaged in the production, processing, and marketing of high-quality hybrid seeds, Pesticides, micronutrients, and many more hit a 5 percent upper circuit following capacity expansion. 

Price Action 

With a market capitalization of Rs. 292 Crores, the shares of Nirman Agri Genetics Limited hit a 5 percent upper circuit in the day’s trade at Rs. 364.65 per equity share, from its previous day’s close price of Rs. 347.30. 

What Happened 

Nirman Agri Genetics Limited has successfully setup a new processing plant impact on production & processing capacity across all product portfolios. The new setup of the processing plant will ultimately support increasing margins and revenue. 

The new Hi-end processing plant was set up with an investment of Rs. 3 Crores from the company’s existing funds with a capacity of 10 Ton per hour being added to the existing processing capacity of the plant. 

Recent Work order 

Recently Nirman Agri Genetics Limited had received a work order from Toshan Seeds Pvt. worth Rs. 10.65 Crores for the supply of seeds. 

About the Company 

Nirman Agri Genetics Limited is engaged in the business of production, processing, and marketing of high-quality hybrid seeds, Pesticides, micronutrients, and Bio-organics for different varieties of crops. 

Financials and Ratios 

Its revenue from operations grew by 356 percent from Rs. 11.04 Crores in Q1FY24 to Rs. 50.35 Crores in Q1FY25, accompanied by profits of Rs. 1.81 Crores to Rs. 5.04 Crores. 

In terms of Return ratios, it has reported a return on equity (ROE) of 32.4 percent and a return on capital employed (ROCE) of 33.8 percent. It has reported a debt-to-equity ratio of 0.02. 

Written by: Bharath K.S

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×